Compositions comprising non-crystalline forms of cannabidiol

US12201605B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12201605-B2
Application numberUS-202117306713-A
CountryUS
Kind codeB2
Filing dateMay 3, 2021
Priority dateApr 26, 2019
Publication dateJan 21, 2025
Grant dateJan 21, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Various aspects of this patent document relate to liquid compositions comprising cannabidiol, which have either freezing points or glass-liquid transition temperatures less than the melting point of pure cannabidiol.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition, comprising cannabidiol at a concentration of at least 50 and no greater than 99.5 percent by mass and one or more solutes selected from terpenes, terpene alcohols, and terpenoids at a combined concentration of at least 0.5 and no greater than 40 percent by mass, wherein: the one or more solutes are dissolved in the cannabidiol; the composition has a freezing point; and the freezing point is less than 21 degrees Celsius. 2. The composition of claim 1 , wherein the composition comprises the cannabidiol at a concentration of at least 75 and no greater than 99 percent by mass. 3. The composition of claim 1 , wherein the composition lacks tetrahydrocannabinol at a concentration greater than 0.3 percent by mass. 4. The composition of claim 1 , wherein: the composition comprises tetrahydrocannabinol at a concentration greater than 0.3 percent by mass; the tetrahydrocannabinol is dissolved in the cannabidiol; and the composition comprises the cannabidiol and the tetrahydrocannabinol at a ratio of at least 3:1 and no greater than 200:1 by mass. 5. The composition of claim 1 , comprising (6aS,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol at a concentration of at least 0.05 and no greater than 5 percent by mass, wherein the (6aS,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol is dissolved in the cannabidiol. 6. The composition of claim 1 , wherein the composition comprises molecules that each have a boiling point of less than 182 degrees Celsius at a combined concentration of at least 95 percent by mass. 7. The composition of claim 1 , wherein the composition lacks propylene glycol, glycerol, triglycerides, phospholipids, fatty acids, and waxes at a combined concentration greater than 5 percent by mass. 8. The composition of claim 1 , wherein the composition is a liquid; the composition has a viscosity; and the viscosity is less than 100 pascal-seconds at a temperature of 21 degrees Celsius. 9. The composition of claim 1 , wherein the one or more solutes comprise one or more of alpha-bisabolol, alpha-phellandrene, alpha-pinene, alpha-terpinene, alpha-terpineol, beta-caryophyllene, beta-pinene, borneol, cadinene, camphene, camphor, caryophyllene oxide, citral, citronellol, delta-3-carene, eucalyptol, eugenol, gamma-terpinene, geraniol, guaiol, humulene, isopulegol, limonene, linalool, myrcene, nerol, nerolidol, ocimene, para-cymene, phytol, pulegone, terpineol, terpinolene, and valencene at a combined concentration of at least 0.5 and no greater than 40 percent by mass. 10. The composition of claim 1 , wherein: the composition comprises the cannabidiol at a concentration of at least 65 and no greater than 99 percent by mass; the composition lacks crystals of cannabidiol; the composition comprises tetrahydrocannabinol at a concentration greater than 0.3 percent by mass; the tetrahydrocannabinol is dissolved in the cannabidiol; the composition comprises the cannabidiol and the tetrahydrocannabinol at a ratio of at least 3:1 and no greater than 200:1 by mass; the one or more solutes comprise one or more of alpha-bisabolol, beta-caryophyllene, guaiol, humulene, limonene, myrcene, and terpinolene at a combined concentration of at least 0.5 and no greater than 35 percent by mass; the composition comprises molecules that each have a boiling point of less than 182 degrees Celsius at a combined concentration of at least 95 percent by mass; the composition lacks propylene glycol, glycerol, triglycerides, phospholipids, fatty acids, and waxes at a combined concentration greater than 5 percent by mass; and the composition is a liquid, the composition has a viscosity, and the viscosity is at least 50 millipascal-seconds and no greater than 50 pascal-seconds at a temperature of 21 degrees Celsius. 11. A composition, comprising cannabidiol at a concentration of at least 50 and no greater than 99.5 percent by mass and one or more solutes selected from terpenes, terpene alcohols, and terpenoids at a combined concentration of at least 0.5 and no greater than 40 percent by mass, wherein: the one or more solutes are dissolved in the cannabidiol; the composition lacks a freezing point; the composition has a glass-liquid transition temperature; and the glass-liquid transition temperature is less than 21 degrees Celsius. 12. The composition of claim 11 , wherein the composition comprises cannabidiol at a concentration of at least 75 and no greater than 99 percent by mass. 13. The composition of claim 11 , wherein the composition lacks tetrahydrocannabinol at a concentration greater than 0.3 percent by mass. 14. The composition of claim 11 , wherein: the composition comprises tetrahydrocannabinol at a concentration greater than 0.3 percent by mass; the tetrahydrocannabinol is dissolved in the cannabidiol; and the composition comprises the cannabidiol and the tetrahydrocannabinol at a ratio of at least 3:1 and no greater than 200:1 by mass. 15. The composition of claim 11 , comprising (6aS,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol at a concentration of at least 0.05 and no greater than 5 percent by mass, wherein the (6aS,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol is dissolved in the cannabidiol. 16. The composition of claim 11 , wherein the composition comprises molecules that each have a boiling point of less than 182 degrees Celsius at a combined concentration of at least 95 percent by mass. 17. The composition of claim 11 , wherein the composition lacks propylene glycol, glycerol, triglycerides, phospholipids, fatty acids, and waxes at a combined concentration greater than 5 percent by mass. 18. The composition of claim 11 , wherein the composition is a liquid; the composition has a viscosity; and the viscosity is less than 100 pascal-seconds at a temperature of 21 degrees Celsius. 19. The composition of claim 11 , wherein the one or more solutes comprise one or more of alpha-bisabolol, alpha-phellandrene, alpha-pinene, alpha-terpinene, alpha-terpineol, beta-caryophyllene, beta-pinene, borneol, cadinene, camphene, camphor, caryophyllene oxide, citral, citronellol, delta-3-carene, eucalyptol, eugenol, gamma-terpinene, geraniol, guaiol, humulene, isopulegol, limonene, linalool, myrcene, nerol, nerolidol, ocimene, para-cymene, phytol, pulegone, terpineol, terpinolene, and valencene at a combined concentration of at least 0.5 and no greater than 40 percent by mass. 20. The composition of claim 11 , wherein: the composition comprises cannabidiol at a concentration of at least 65 and no greater than 99 percent by mass; the composition lacks crystals of cannabidiol; the composition comprises tetrahydrocannabinol at a concentration greater than 0.3 percent by mass; the tetrahydrocannabinol is dissolved in the cannabidiol; the composition comprises the cannabidiol and the tetrahydrocannabinol at a ratio of at least 3:1 and no greater than 200:1 by mass; the one or more solutes comprise one or more of alpha-bisabolol, beta-caryophyllene, guaiol, humulene, limonene, myrcene, and terpinolene at a combined concentration of at least 0.5 and no greater than 35 percent by mass; the composition comprises molecules that each have a boiling point of less than 182 degrees Celsius at a combined concentration of at least 95 percent by mass; the composition lacks propylene glycol, glycerol, triglycerides, phospholipids, fatty acids, and waxes at a combined concentration gre

Assignees

Inventors

Classifications

  • Cannabis · CPC title

  • A61K31/658Primary

    o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol · CPC title

  • Cannabaceae · CPC title

  • Theobroma, e.g. cocao or cocoa · CPC title

  • Humulus · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12201605B2 cover?
Various aspects of this patent document relate to liquid compositions comprising cannabidiol, which have either freezing points or glass-liquid transition temperatures less than the melting point of pure cannabidiol.
Who is the assignee on this patent?
Natural Extraction Sys Llc
What technology area does this patent fall under?
Primary CPC classification A61K31/658. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).